---
figid: PMC6442683__nihms-1005382-f0004
figlink: /pmc/articles/PMC6442683/figure/F4/
number: F4
caption: Within the dendritic spine, AMPA receptors (AMPARs) govern fast synaptic
  transmission in response to glutamatergic signalling. Glutamate binds to, and activates,
  AMPARs in response to synaptic activity. The resulting influx of sodium and potassium
  ions through the open channel results in depolarization. NMDA receptor (NMDAR) activation
  occurs in response to glycine and glutamate binding concurrently with depolarization.
  In addition, depolarization results in the opening of voltage-gated calcium channels
  (VGCCs; including L-type, Cav1.2/1.3-containing channels). Depolarization and VGCC
  activation result in brain-derived neurotrophic factor (BDNF) exocytosis. Calcium
  influx activates calcium/calmodulin-dependent kinase type II (CAMKII), resulting
  in activation of GTPase signalling by phosphorylation of kalirin and/ or triple
  functional domain protein (TRIO). These guanine nucleotide exchange factors regulate
  RAS-related C3 botulinum toxin substrate 1 (RAC)/transforming protein RhoA (RHOA)
  to alter cytoskeletal dynamics. GTPase activation can either increase (RAC pathway)
  or decrease (RHOA pathway) actin polymerization through serine/threonine protein
  kinase PAK (PAK) or Rho-associated protein kinase (ROCK) pathways to promote spine
  growth or retraction, respectively,. In addition, calcium results in the activation
  of eukaryotic elongation factor 2 kinase (eEF2K), phosphorylation of elongation
  factor 2 (EF2) at Thr56 (REF. ) and inhibition of BDNF translation at ribosomes.
  BDNF release results in the activation of the BDNF/NT3 growth factor receptor (TRKB;
  also known as NTRK2) and induction of the RAS pathway through growth factor receptor-bound
  protein 2 (GRB2) and son of sevenless homologue 1 (SOS1; not shown), which in turn
  activates the phosphatidylinositol 3-kinase (PI3K) and MEK (MAPK/ERK kinase) and/
  or extracellular-signal-regulated kinase (ERK) pathways, contributing to long-term
  potentiation via AMPAR trafficking and membrane insertion within the spine. Many
  regulatory compounds targeting key synaptic signalling proteins have been isolated
  (indicated in the pink boxes). These, or other related small molecules, may have
  utility in neuropsychiatric disorders by regulating synaptic function and spine
  dynamics. CCBs, calcium channel blockers; FTIs, farnesyl transferase inhibitors;
  mTOR, mammalian target of rapamycin; PAM, positive allosteric modulator; TARP, transmembrane
  AMPAR regulator protein. TRIPα, TRIO inhibitory aptamer; Question mark indicates
  unknown mechanism.
pmcid: PMC6442683
papertitle: Dendritic structural plasticity and neuropsychiatric disease.
reftext: Marc P. Forrest, et al. Nat Rev Neurosci. 2018 Mar 16;19(4):215-234.
pmc_ranked_result_index: '95956'
pathway_score: 0.9648427
filename: nihms-1005382-f0004.jpg
figtitle: Dendritic structural plasticity and neuropsychiatric disease
year: '2018'
organisms:
- Mus musculus
- Rattus norvegicus
- Phleum pratense
- Agaricus bisporus
- Homo sapiens
ndex: d8a355c7-ded3-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6442683__nihms-1005382-f0004.html
  '@type': Dataset
  description: Within the dendritic spine, AMPA receptors (AMPARs) govern fast synaptic
    transmission in response to glutamatergic signalling. Glutamate binds to, and
    activates, AMPARs in response to synaptic activity. The resulting influx of sodium
    and potassium ions through the open channel results in depolarization. NMDA receptor
    (NMDAR) activation occurs in response to glycine and glutamate binding concurrently
    with depolarization. In addition, depolarization results in the opening of voltage-gated
    calcium channels (VGCCs; including L-type, Cav1.2/1.3-containing channels). Depolarization
    and VGCC activation result in brain-derived neurotrophic factor (BDNF) exocytosis.
    Calcium influx activates calcium/calmodulin-dependent kinase type II (CAMKII),
    resulting in activation of GTPase signalling by phosphorylation of kalirin and/
    or triple functional domain protein (TRIO). These guanine nucleotide exchange
    factors regulate RAS-related C3 botulinum toxin substrate 1 (RAC)/transforming
    protein RhoA (RHOA) to alter cytoskeletal dynamics. GTPase activation can either
    increase (RAC pathway) or decrease (RHOA pathway) actin polymerization through
    serine/threonine protein kinase PAK (PAK) or Rho-associated protein kinase (ROCK)
    pathways to promote spine growth or retraction, respectively,. In addition, calcium
    results in the activation of eukaryotic elongation factor 2 kinase (eEF2K), phosphorylation
    of elongation factor 2 (EF2) at Thr56 (REF. ) and inhibition of BDNF translation
    at ribosomes. BDNF release results in the activation of the BDNF/NT3 growth factor
    receptor (TRKB; also known as NTRK2) and induction of the RAS pathway through
    growth factor receptor-bound protein 2 (GRB2) and son of sevenless homologue 1
    (SOS1; not shown), which in turn activates the phosphatidylinositol 3-kinase (PI3K)
    and MEK (MAPK/ERK kinase) and/ or extracellular-signal-regulated kinase (ERK)
    pathways, contributing to long-term potentiation via AMPAR trafficking and membrane
    insertion within the spine. Many regulatory compounds targeting key synaptic signalling
    proteins have been isolated (indicated in the pink boxes). These, or other related
    small molecules, may have utility in neuropsychiatric disorders by regulating
    synaptic function and spine dynamics. CCBs, calcium channel blockers; FTIs, farnesyl
    transferase inhibitors; mTOR, mammalian target of rapamycin; PAM, positive allosteric
    modulator; TARP, transmembrane AMPAR regulator protein. TRIPα, TRIO inhibitory
    aptamer; Question mark indicates unknown mechanism.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CA2
  - BDNF
  - HRAS
  - NRAS
  - CAMK2B
  - EEF2
  - KRAS
  - MAPK1
  - RAC2
  - RAC3
  - EEF2K
  - GRIN2A
  - GRIN3A
  - GRIN3B
  - MTOR
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN1
  - RHOG
  - RAC1
  - MAP2K1
  - MAP2K2
  - PAK1
  - PAM
  - PIK3R3
  - PIK3CD
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CG
  - MAPK3
  - KALRN
  - PAK5
  - PAK2
  - ROCK1
  - ROCK2
  - TRIO
  - RHOA
  - PAK6
  - PAK3
  - PAK4
  - NTRK2
  - Ketamine
  - ORG26576
  - Piracetam
  - Aniracetam
  - Memantine
  - ketamine
  - Glycine
  - Cycloserine
  - Fasudil
  - Nifedpine
  - Verapamil
  - Diltiazem
  - Ca
  - Na
  - Secramine
  - Statins
  - Prenyl
genes:
- word: Ca²
  symbol: CA-II
  source: hgnc_alias_symbol
  hgnc_symbol: CA2
  entrez: '760'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: CAMKII
  symbol: CAMK2
  source: hgnc_alias_symbol
  hgnc_symbol: CAMK2B
  entrez: '816'
- word: EEF2
  symbol: EEF2
  source: hgnc_symbol
  hgnc_symbol: EEF2
  entrez: '1938'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: •ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: EEF2K
  symbol: EEF2K
  source: hgnc_symbol
  hgnc_symbol: EEF2K
  entrez: '29904'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: RAC
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: •MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: •MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PAM
  symbol: PAM
  source: hgnc_symbol
  hgnc_symbol: PAM
  entrez: '5066'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: •PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: •ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Kalirin
  symbol: Kalirin
  source: hgnc_alias_symbol
  hgnc_symbol: KALRN
  entrez: '8997'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: Rock
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
- word: Rock
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: TRIO
  symbol: TRIO
  source: hgnc_symbol
  hgnc_symbol: TRIO
  entrez: '7204'
- word: RHOA
  symbol: RHOA
  source: hgnc_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: TRKB
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
chemicals:
- word: Ketamine
  source: MESH
  identifier: D007649
- word: ORG26576
  source: MESH
  identifier: C545643
- word: Piracetam
  source: MESH
  identifier: D010889
- word: Aniracetam
  source: MESH
  identifier: C036466
- word: Memantine
  source: MESH
  identifier: D008559
- word: ketamine
  source: MESH
  identifier: D007649
- word: Glycine
  source: MESH
  identifier: D005998
- word: Cycloserine
  source: MESH
  identifier: D003523
- word: Fasudil
  source: MESH
  identifier: C049347
- word: Nifedpine
  source: ''
  identifier: ''
- word: Verapamil
  source: MESH
  identifier: D014700
- word: Diltiazem
  source: MESH
  identifier: D004110
- word: Ca
  source: MESH
  identifier: D002118
- word: Na
  source: MESH
  identifier: D012964
- word: Secramine
  source: MESH
  identifier: C508970
- word: Statins
  source: MESH
  identifier: D019821
- word: Prenyl
  source: MESH
  identifier: C016077
diseases: []
figid_alias: PMC6442683__F4
redirect_from: /figures/PMC6442683__F4
figtype: Figure
---
